Our Scientific Advisory Board

The members of the BroadRiver Scientific Advisory Board keep the team abreast of academic and industry developments in their area of expertise and identify and recommend specific research initiatives for BroadRiver to commission. BroadRiver is vitally interested in current developments in scientific fields relevant to its investment focus, including epidemiology, aging, financial mathematics, and actuarial science. For example, BroadRiver has commissioned proprietary research in mathematical portfolio theory at a leading university mathematics department to examine the effect of BroadRiver’s non-correlated asset classes on conventional equity/fixed-income portfolios.

Members of the Scientific Advisory Board

Dr. Leonid Gavrilov Senior Research Scientist
Center on Aging, NORC
The University of Chicago
Dr. Natalia Gavrilova Senior Research Scientist
Center on Aging, NORC
The University of Chicago
Dr. David Jacobs Professor, School of Public Health
Division of Epidemiology & Community Health
University of Minnesota
Dr. Jay Olshansky Professor, School of Public Health
University of Illinois at Chicago
Mr. Phil Loy President
Berkshire Settlements